Doxepin's Effect on Blood Pressure
Doxepin can cause orthostatic hypotension, particularly in elderly patients and those with cardiovascular disease, but it is not recommended as an antihypertensive medication due to its side effect profile and the availability of more effective alternatives. 1, 2
Mechanism and Cardiovascular Effects
Doxepin is a tricyclic antidepressant (TCA) with the following cardiovascular effects:
- Blood pressure effects: Can cause orthostatic hypotension (a significant drop in blood pressure upon standing) 2
- Cardiac conduction: Slows cardiac conduction similar to other TCAs 1, 2
- Heart rate: Limited robust effect on heart rate 2
- Antiarrhythmic properties: Shows some antiarrhythmic effects 2
Clinical Considerations
Patient Tolerance and Safety
- Despite common belief that doxepin might be safer for cardiac patients, research shows its cardiovascular effects are comparable to other TCAs like imipramine and nortriptyline 1, 2
- In a study of depressed patients with preexisting cardiac conditions:
- 16% dropped out due to cardiovascular side effects
- Overall dropout rate was 41%
- Significant increase in orthostatic hypotension was observed 2
Comparison to Other Antidepressants
- Selective Serotonin Reuptake Inhibitors (SSRIs) have limited effects on autonomic system activity and lower impact on blood pressure, making them safer for elderly and cardiovascular patients 3
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), particularly venlafaxine, carry a greater risk of hypertension 3
- TCAs including doxepin have been associated with both increases in blood pressure and orthostatic hypotension 3
Recommendations for Clinical Practice
When Managing Hypertension
- Doxepin is not recommended as a primary or adjunctive treatment for hypertension
- For hypertension management, guidelines recommend:
- Thiazide diuretics or calcium channel blockers as first-line agents for elderly patients 4
- For resistant hypertension, adding spironolactone (25-50mg daily) is recommended 4
- Alpha-1 blockers like doxazosin (not to be confused with doxepin) may be considered as second-line agents, particularly in patients with benign prostatic hyperplasia 4, 5
When Prescribing Doxepin
- Monitor for orthostatic hypotension, especially in:
- Measure blood pressure in both sitting and standing positions before and after initiating therapy 4
- Start with lower doses in elderly patients (half the usual adult dose) 4
- Be aware that doxepin's hypotensive effects may complicate treatment in patients already on antihypertensive medications
Conclusion
While doxepin may cause blood pressure lowering effects through orthostatic hypotension, this is considered an adverse effect rather than a therapeutic benefit. For patients requiring blood pressure management, evidence-based antihypertensive medications should be used instead of relying on the side effects of tricyclic antidepressants.